Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug-resistant Focal Seizure”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Not applicableActive Not RecruitingNCT05248269
What this trial is testing

Thermocoagulation in Drug Resistant Focal Epilepsy

Who this might be right for
EpilepsySeizures, FocalEpilepsy Intractable+1 more
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia 75
Post-approval studies (Phase 4)Ended earlyNCT05605756
What this trial is testing

BOTOX Effects on Seizure Severity and Susceptibility

Who this might be right for
Drug-resistant Focal Seizure
Beth Israel Deaconess Medical Center 3
Testing effectiveness (Phase 2)Study completedNCT01159431
What this trial is testing

External Trigeminal Nerve Stimulation for Epilepsy

Who this might be right for
EpilepsySeizure Disorders
Olive View-UCLA Education & Research Institute 50
Early research (Phase 1)Active Not RecruitingNCT06899230
What this trial is testing

Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of iQ-007

Who this might be right for
Drug Resistant EpilepsyFocal Seizure
iQure Australia Pty Ltd 72
Testing effectiveness (Phase 2)Study completedNCT03283371
What this trial is testing

Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy

Who this might be right for
Epilepsy, Focal Seizures, Partial Seizures
Biogen 67
Early research (Phase 1)Looking for participantsNCT02531880
What this trial is testing

Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

Who this might be right for
Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS) 40
Not applicableLooking for participantsNCT04770337
What this trial is testing

Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

Who this might be right for
Refractory EpilepsyFocal SeizureSeizures, Focal+4 more
Neuroelectrics Corporation 190
Large-scale testing (Phase 3)Ended earlyNCT02519439
What this trial is testing

A Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset Seizures

Who this might be right for
Drug Resistant Partial Onset Seizure
Marinus Pharmaceuticals 26
Testing effectiveness (Phase 2)Study completedNCT04244175
What this trial is testing

A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Who this might be right for
Seizures
AbbVie 154
Not applicableLooking for participantsNCT07012148
What this trial is testing

Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables

Who this might be right for
Focal EpilepsyGeneralized SeizureDrug Refractory Epilepsy
Mayo Clinic 12
Testing effectiveness (Phase 2)Ended earlyNCT04686786
What this trial is testing

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Who this might be right for
Seizures
AbbVie 105
Large-scale testing (Phase 3)Looking for participantsNCT06309966
What this trial is testing

Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 390
Large-scale testing (Phase 3)Looking for participantsNCT05135091
What this trial is testing

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

Who this might be right for
Mesial Temporal Lobe Epilepsy
Neurona Therapeutics 88
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06443463
What this trial is testing

Long-term Safety and Tolerability of BHV-7000

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 660
Post-approval studies (Phase 4)Ended earlyNCT04650204
What this trial is testing

Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy

Who this might be right for
Intractable EpilepsyMalignant GliomaSeizure Disorder+2 more
Mayo Clinic 4
Testing effectiveness (Phase 2)Ended earlyNCT02625090
What this trial is testing

An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy

Who this might be right for
Highly Drug-resistant Focal Epilepsy
UCB Biopharma SRL 42
Large-scale testing (Phase 3)Study completedNCT01963208
What this trial is testing

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

Who this might be right for
Drug Resistant Partial Onset Seizure
Marinus Pharmaceuticals 405
Large-scale testing (Phase 3)Looking for participantsNCT06132893
What this trial is testing

Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 390
Large-scale testing (Phase 3)Ended earlyNCT03739840
What this trial is testing

Test the Efficacy and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

Who this might be right for
Drug-Resistant EpilepsyFocal-Onset Seizures
UCB Biopharma SRL 232
Testing effectiveness (Phase 2)Study completedNCT00210652
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

Who this might be right for
EpilepsyEpilepsies, Partial
SK Life Science, Inc. 47
Load More Results